Analyst Consensus ?
ConsensusBuy27 ratings
Bullish1970.4%
Neutral829.6%
Bearish00.0%
FN2 Earnings Intelligence
Zebra Technologies Corporation analyst ratings
Zebra Technologies Corporation (ZBRA) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$351.41Current
$256Low
$365.67Average
$500High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 14, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Truist Securities | Hold | Hold | Maintain | Aug 5, 2026 |
| TD Cowen | Buy | Buy | Maintain | Aug 5, 2026 |
| Needham | Buy | Buy | Maintain | Aug 5, 2026 |
| Keybanc | Overweight | Overweight | Maintain | Aug 5, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Aug 5, 2026 |
| BNP Paribas | Outperform | Outperform | Maintain | Aug 5, 2026 |
| Barclays | Overweight | Overweight | Maintain | Aug 5, 2026 |
| Baird | Outperform | Outperform | Maintain | May 13, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Aug 6, 2025 |
| UBS | Buy | Buy | Maintain | Apr 30, 2025 |
| Stephens & Co. | Overweight | Overweight | Maintain | Aug 2, 2024 |
| Exane BNP Paribas | Neutral | Underperform | Upgrade | Jun 13, 2024 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Apr 8, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | Aug 2, 2023 |
| JP Morgan | Overweight | Neutral | Upgrade | Apr 4, 2022 |
| Northcoast Research | Buy | Neutral | Upgrade | Mar 23, 2021 |
| Imperial Capital | Outperform | Outperform | Maintain | Nov 20, 2019 |
| Atlantic Equities | Overweight | Overweight | Maintain | Aug 27, 2019 |
| Berenberg | Buy | Buy | Maintain | Mar 7, 2019 |
| Wells Fargo | Market Perform | Market Perform | Maintain | Feb 27, 2018 |
| Wellington Shields | Buy | Hold | Upgrade | Nov 8, 2017 |
| CLSA | Buy | Buy | Maintain | Aug 3, 2016 |
| Goldman Sachs | Neutral | Neutral | Maintain | Jun 8, 2016 |
| Avondale Partners | Perform | Market Perform | Maintain | Mar 28, 2016 |
| Oppenheimer | Outperform | Outperform | Maintain | Jan 20, 2016 |
| Barrington Research | Outperform | Outperform | Maintain | Aug 26, 2015 |
| Sidoti & Co. | Neutral | Buy | Downgrade | Jan 28, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $351.41. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Truist Financial | Analyst unavailable | $355 | $373.87 | +1.0% | Aug 5, 2026 |
| Morgan Stanley | Meta Marshall | $360 | $373.76 | +2.4% | Aug 5, 2026 |
| KeyBanc | Analyst unavailable | $430 | $368.83 | +22.4% | Aug 5, 2026 |
| Barclays | Analyst unavailable | $410 | $368.83 | +16.7% | Aug 5, 2026 |
| Wolfe Research | Analyst unavailable | $317 | $271 | -9.8% | Jul 9, 2026 |
| Truist Financial | Analyst unavailable | $296 | $267.85 | -15.8% | Jul 2, 2026 |
| Barclays | Analyst unavailable | $346 | $245.69 | -1.5% | Jun 23, 2026 |
| Barclays | Guy Hardwick | $345 | $241.79 | -1.8% | May 13, 2026 |
| KeyBanc | Analyst unavailable | $305 | $241.79 | -13.2% | May 13, 2026 |
| Robert W. Baird | Analyst unavailable | $310 | $241.79 | -11.8% | May 13, 2026 |
| Truist Financial | Jamie Cook | $256 | $236.14 | -27.2% | Apr 20, 2026 |
| UBS | Damian Karas | $335 | $268.88 | -4.7% | Feb 13, 2026 |
| Barclays | Analyst unavailable | $330 | $274.15 | -6.1% | Feb 13, 2026 |
| Morgan Stanley | Meta Marshall | $323 | $274.15 | -8.1% | Feb 12, 2026 |
| Barclays | Guy Hardwick | $351 | $241.08 | -0.1% | Feb 6, 2026 |
| Barclays | Guy Hardwick | $368 | $259.48 | +4.7% | Jan 12, 2026 |
| Truist Financial | Jamie Cook | $291 | $254.22 | -17.2% | Dec 18, 2025 |
| Truist Financial | Analyst unavailable | $331 | $275.96 | -5.8% | Oct 29, 2025 |
| Barclays | Analyst unavailable | $360 | $274.31 | +2.4% | Oct 29, 2025 |
| Truist Financial | Analyst unavailable | $350 | $296.64 | -0.4% | Oct 8, 2025 |
| Barclays | Analyst unavailable | $375 | $296.64 | +6.7% | Oct 7, 2025 |
| Barclays | Tim Long | $301 | $302.6 | -14.3% | Aug 5, 2025 |
| UBS | Damian Karas | $425 | $318.36 | +20.9% | Feb 18, 2025 |
| Robert W. Baird | Analyst unavailable | $380 | $331.08 | +8.1% | Feb 18, 2025 |
| Truist Financial | Jamie Cook | $383 | $384.68 | +9.0% | Oct 29, 2024 |
| Robert W. Baird | Richard Eastman | $375 | $348.12 | +6.7% | Jul 31, 2024 |
| Truist Financial | Jamie Cook | $345 | $348.12 | -1.8% | Jul 31, 2024 |
| BNP Paribas | Andrew Buscaglia | $305 | $304.56 | -13.2% | Jun 13, 2024 |
| Needham | James Ricchiuti | $370 | $323.87 | +5.3% | May 16, 2024 |
| Robert W. Baird | Richard Eastman | $330 | $314.56 | -6.1% | May 1, 2024 |
| Stephens | Tommy Moll | $380 | $314.56 | +8.1% | May 1, 2024 |
| Wolfe Research | Brad Hewitt | $337 | $290.38 | -4.1% | Apr 8, 2024 |
| Truist Financial | Jamie Cook | $300 | $284.5 | -14.6% | Mar 13, 2024 |
| Needham | James Ricchiuti | $255 | $196.82 | -27.4% | Nov 1, 2023 |
| Morgan Stanley | Analyst unavailable | $260 | $270.82 | -26.0% | Dec 13, 2022 |
| Credit Suisse | Analyst unavailable | $319 | $258.1 | -9.2% | Dec 13, 2022 |
| UBS | Analyst unavailable | $495 | $325.44 | +40.9% | Aug 4, 2022 |
| Stephens | Analyst unavailable | $500 | $323.32 | +42.3% | Aug 3, 2022 |
| Needham | Analyst unavailable | $450 | $323.32 | +28.1% | Aug 3, 2022 |
| Needham | Analyst unavailable | $500 | $368.14 | +42.3% | May 4, 2022 |
| Morgan Stanley | Meta Marshall | $400 | $393.68 | +13.8% | Apr 16, 2022 |
| Wolfe Research | Brian Lau | $469 | $437.18 | +33.5% | Mar 20, 2022 |
| Needham | James Ricchiuti | $535 | $388.79 | +52.2% | Mar 10, 2022 |
Track every rating change on ZBRA the moment it posts. Free to start.
Start free